EDF1 coordinates cellular responses to ribosome collisions
- Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, United States
- Harvard Medical School, United States
- Ludwig Maximilian University of Munich, Germany
- University of California, San Diego, United States
- Gene Center, Ludwig-Maximilians-Universität München, Germany
Abstract
Translation of aberrant mRNAs induces ribosomal collisions, thereby triggering pathways for mRNA and nascent peptide degradation and ribosomal rescue. Here we use sucrose gradient fractionation combined with quantitative proteomics to systematically identify proteins associated with collided ribosomes. This approach identified Endothelial differentiation-related factor 1 (EDF1) as a novel protein recruited to collided ribosomes during translational distress. Cryo-electron microscopic analyses of EDF1 and its yeast homolog Mbf1 revealed a conserved 40S ribosomal subunit binding site at the mRNA entry channel near the collision interface. EDF1 recruits the translational repressors GIGYF2 and EIF4E2 to collided ribosomes to initiate a negative-feedback loop that prevents new ribosomes from translating defective mRNAs. Further, EDF1 regulates an immediate-early transcriptional response to ribosomal collisions. Our results uncover mechanisms through which EDF1 coordinates multiple responses of the ribosome-mediated quality control pathway and provide novel insights into the intersection of ribosome-mediated quality control with global transcriptional regulation.
Data availability
Raw mass spectrometry data associated with the following Figures have been deposited in MassIVE repository: Source data for all proteomics-based plots are provided in Source data tables.Figure 1, Figure 1-figure supplement 1: https://doi.org/doi:10.25345/C5T70C(Username: MSV000085423_reviewer | Password: a)Figure 2, Figure 2-figure supplement 1: https://doi.org/doi:10.25345/C5B71D(Username: MSV000085419_reviewer | Password: a)Figure 2-figure supplement 2A: https://doi.org/doi:10.25345/C5Z11X(Username: MSV000085422_reviewer | Password: a)Figure 2H, Figure 2-figure supplement 2F: https://doi.org/doi:10.25345/C5JQ47(Username: MSV000085425_reviewer | Password: a)Figure 5A: https://doi.org/doi:10.25345/C5PH7J(Username: MSV000085424_reviewer | Password: a)Figure 5B, Figure 5-figure supplement 1B-1C: https://doi.org/doi:10.25345/C52Q58(Username: MSV000085421_reviewer | Password: a)Figure 6B-6C, Figure 6-figure supplement 1: https://doi.org/doi:10.25345/C56H6T(Username: MSV000085420_reviewer | Password: a)Raw sequencing data were deposited in the GEO database under the accession number GSE149565. Secure token for reviewers: uzajoeeultgrpsr.The cryo-EM structures reported here have been deposited in the Protein Data Bank under the accession codes 6ZVH (EDF1•ribosome) and 6ZVI (Mbf1•ribosome), and in the Electron Microscopy Data Bank under the accession codes EMD-11456 (EDF1•ribosome) and EMD-11457 (Mbf1•ribosome).
-
EDF1 coordinates cellular responses to ribosome collisions, related to Figure 5B, Figure 5-figure supplement 1B-1CMassIVE, MSV000085421_reviewer | Password: a).
Article and author information
Author details
Elayanambi Sundaramoorthy
Danielle M Garshott
Funding
Howard Hughes Medical Institute
- Rachel Green
Deutsche Forschungsgemeinschaft (GRK 1721)
- Roland Beckmann
Deutsche Forschungsgemeinschaft (QBM (Quantitative Biosciences Munich) Graduate School Fellowships)
- Katharina Best
Deutsche Forschungsgemeinschaft (QBM (Quantitative Biosciences Munich) Graduate School Fellowships)
- Timo Denk
National Institute of General Medical Sciences (R37GM059425)
- Rachel Green
National Institute of Neurological Disorders and Stroke (R37NS083524)
- Wade Harper
National Institute on Aging (AG011085)
- Wade Harper
National Institute of General Medical Sciences (DP2GM119132)
- Eric J Bennett
National Institute of General Medical Sciences (5K99GM135450-02)
- Boris Zinshteyn
Jane Coffin Childs Memorial Fund for Medical Research
- Niladri K Sinha
National Institute of General Medical Sciences (T32GM007240)
- Danielle M Garshott
National Science Foundation (DGE-1650112)
- Danielle M Garshott
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Nahum Sonenberg, McGill University, Canada
Version history
- Received: May 12, 2020
- Accepted: August 2, 2020
- Accepted Manuscript published: August 3, 2020 (version 1)
- Version of Record published: September 11, 2020 (version 2)
Copyright
© 2020, Sinha et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 10,166
- views
-
- 1,616
- downloads
-
- 100
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
EDF1 coordinates cellular responses to ribosome collisions
eLife 9:e58828.
https://doi.org/10.7554/eLife.58828
Further reading
-
- Biochemistry and Chemical Biology
- Microbiology and Infectious Disease
To date, all major modes of monoclonal antibody therapy targeting SARS-CoV-2 have lost significant efficacy against the latest circulating variants. As SARS-CoV-2 omicron sublineages account for over 90% of COVID-19 infections, evasion of immune responses generated by vaccination or exposure to previous variants poses a significant challenge. A compelling new therapeutic strategy against SARS-CoV-2 is that of single-domain antibodies, termed nanobodies, which address certain limitations of monoclonal antibodies. Here, we demonstrate that our high-affinity nanobody repertoire, generated against wild-type SARS-CoV-2 spike protein (Mast et al., 2021), remains effective against variants of concern, including omicron BA.4/BA.5; a subset is predicted to counter resistance in emerging XBB and BQ.1.1 sublineages. Furthermore, we reveal the synergistic potential of nanobody cocktails in neutralizing emerging variants. Our study highlights the power of nanobody technology as a versatile therapeutic and diagnostic tool to combat rapidly evolving infectious diseases such as SARS-CoV-2.
-
- Biochemistry and Chemical Biology
Phosphoinositide 3-kinase (PI3K) beta (PI3Kβ) is functionally unique in the ability to integrate signals derived from receptor tyrosine kinases (RTKs), G-protein coupled receptors, and Rho-family GTPases. The mechanism by which PI3Kβ prioritizes interactions with various membrane-tethered signaling inputs, however, remains unclear. Previous experiments did not determine whether interactions with membrane-tethered proteins primarily control PI3Kβ localization versus directly modulate lipid kinase activity. To address this gap in our knowledge, we established an assay to directly visualize how three distinct protein interactions regulate PI3Kβ when presented to the kinase in a biologically relevant configuration on supported lipid bilayers. Using single molecule Total Internal Reflection Fluorescence (TIRF) Microscopy, we determined the mechanism controlling PI3Kβ membrane localization, prioritization of signaling inputs, and lipid kinase activation. We find that auto-inhibited PI3Kβ prioritizes interactions with RTK-derived tyrosine phosphorylated (pY) peptides before engaging either GβGγ or Rac1(GTP). Although pY peptides strongly localize PI3Kβ to membranes, stimulation of lipid kinase activity is modest. In the presence of either pY/GβGγ or pY/Rac1(GTP), PI3Kβ activity is dramatically enhanced beyond what can be explained by simply increasing membrane localization. Instead, PI3Kβ is synergistically activated by pY/GβGγ and pY/Rac1 (GTP) through a mechanism consistent with allosteric regulation.
